BT
Briacell Therapeutics Corp
🇨🇦XTSE.BCTCanadaHealthcare
CA$5.42CADdown -0.07 (-1.28%)OpenEnd of day3:23 PM
PriceCA$5.42-0.07 (-1.28%)
Profile
- Healthcare
- Biotechnology
- Canada
Identity
- Exchange
- Toronto Stock Exchange . XTSE
- Type
- Stock
- ISIN
- CA10778Y3023
- CUSIP
- Not reported
Company
- Employees
- 0
- Headquarters
- West Vancouver, United States
- Website
- https://briacell.com
- CEO
- Dr. William V. Williams FCPA, M.D.
Market
- Shares outstanding
- 1.9M
- Market cap
- CA$10.21M
Highlights
- Market cap
- CA$10.21M
- EPS LTM
- -$13.23
- P/E LTM
- -0.32
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $225.34K+893.96%up year on year
- Net income
- -$37.06M-34.78%down year on year
- Gross margin
- 45.31%+107.97%up year on year
- Free cash flow
- -$37.07M-7.69%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.